Steglatro (Ertugliflozin)

Type

Product

Manufacturer

Country

Dosage

Qty-Price (USD)

Type:

Product: Steglatro Tablet

Manufacturer: MSD

Country: United Kingdom

Dosage: 5 mg

Qty-Price (USD):

Type:

Product: Steglatro Tablet

Manufacturer: MSD

Country: United Kingdom

Dosage: 15 mg

Qty-Price (USD):

Generic Equivalent of Steglatro

Type

Product

Manufacturer

Country

Dosage

Qty-Price (USD)

There is no generic product of Steglatro.

Steglatro Information

medically reviewed by Dr. HaVy Ngo, Pharmacist on December 16, 2025.

Steglatro at CanadaPharmacyOnline.com

Brand Steglatro (ertugliflozin) is manufactured by MSD in many countries worldwide, including the United Kingdom. The generic ertugliflozin is currently unavailable at this pharmacy.

Dosage:

The brand Steglatro is available as 5 mg and 15 mg oral tablets.

Your doctor will determine the appropriate dose based on your individual needs and medical conditions.

Usage:

Steglatro (ertugliflozin) is a prescription medication primarily used to improve blood sugar control in adults with type 2 diabetes and lower the risk of diabetes-related complications. Type 2 diabetes occurs when the body cannot use insulin efficiently or does not make enough insulin. Steglatro helps lower blood sugar by promoting the excretion of excess glucose through the urine. The drug also supports modest weight reduction and reduced blood pressure in some patients.

Mechanism of Action:
Steglatro (ertugliflozin) is an SGLT2 inhibitor. It blocks the SGLT2 protein in the kidneys, reducing glucose reabsorption. It also increases glucose excretion through urine. This action helps reduce fasting and post-meal blood sugar while also supporting modest weight loss and lower blood pressure in some individuals.

Take Steglatro exactly as your doctor prescribes, following the instructions in the Product Monograph in Canada accompanying the medication. Consult your doctor for personalized guidance and safe use.

The information below summarizes some, but not all, potential side effects, risks, and interactions. Before taking Steglatro, it is essential to discuss all possible side effects, risks, and interactions with your doctor or pharmacist.

Side Effects:

The information below outlines potential side effects associated with Steglatro (ertugliflozin). It is not an exhaustive list, and individual reactions can vary. This information is for educational purposes and should not replace professional medical advice. Before starting Steglatro, it is crucial to discuss possible side effects and risks with your doctor or pharmacist.

Common side effects - These are common side effects of Steglatro; others are possible. Contact your doctor promptly if any side effects persist, worsen, or concern you, or if you experience any other concerning symptoms.
• Back pain;
• Frequent thirst;
• Increased cholesterol levels;
• Increased urination;
• Mild dehydration;
• Urinary tract infections

Serious or rare side effects- Seek immediate medical attention or call emergency services if you experience any of the following:
• Fournier's gangrene, including pain, tenderness, swelling, or redness of the genital or perineal area, accompanied by fever or feeling unwell;
• Severe genital infections;
• Severe urinary infections;
• Signs of diabetic ketoacidosis, including nausea, vomiting, stomach pain, confusion, and deep breathing;
• Signs of severe allergic reaction, including rash, swelling, and breathing troubles;
• Signs of severe dehydration, including dizziness and a fast heartbeat

Contraindications:

The following is not an exhaustive list of contraindications. Before starting Steglatro, it is essential to discuss all your medical conditions, past and present, as well as all medications you are currently taking, with your doctor or pharmacist.

Steglatro should not be used if:
• You have a known allergy to ertugliflozin or any of the ingredients in the medication.
• You have severe kidney disease or are on dialysis
• You have type 1 diabetes, diabetic ketoacidosis (DKA), or a history of DKA

Tell your doctor about all of your medical conditions, past and present, before starting Steglatro. This is crucial because certain conditions can affect whether Steglatro is right for you. These conditions may include, but are not limited to:
• A history of genital yeast infections
• A history of ketoacidosis
• A planned surgery or medical procedure that requires fasting
• Frequent urinary infections
• High levels of triglycerides
• Low blood pressure
• Reduced kidney function

Drug Interactions:

Before taking Steglatro, it is essential to discuss all potential risks and interactions with your doctor or pharmacist. For complete and up-to-date information, refer to the consumer information.

Provide your doctor with a complete list of all your medications, including prescriptions, over-the-counter (OTC) drugs, vitamins, and herbal supplements. It is also essential to inform your doctor about any herbal teas, recreational drugs, or significant dietary changes you are making, as these could potentially interact with Steglatro. Steglatro may interact with other medicines, but is not limited to:
• Drugs that increase the risk of low blood pressure – diuretics can increase the risk of dehydration and low blood pressure when used with Steglatro.
• Drugs that increase the risk of low blood sugar – Using Steglatro with medicines that lower blood sugar, such as glyburide, insulin, or glimepiride, can increase the risk of low blood sugar. Dosage adjustments may be required.

Pregnancy and Breastfeeding:

Steglatro is not recommended during the second and third trimesters of pregnancy, as ertugliflozin may affect fetal kidney development. If you are trying to conceive or become pregnant, your doctor may switch you to a safer alternative. Steglatro is not recommended when breastfeeding. It is unknown if ertugliflozin passes into breast milk. The potential effects on the infant's kidneys make breastfeeding unsafe while using this medication. If you are pregnant, breastfeeding, or planning to become pregnant, it is crucial to consult your doctor immediately.

Frequently Asked Questions about Steglatro at Canada Pharmacy Online:

Why is Steglatro more affordable in Canada than in the United States?

Prescription drug prices, including Steglatro, are generally lower in Canada than in the U.S. due to a combination of factors, primarily government price regulations, differing market dynamics, and other economic considerations. In Canada, provincial and federal governments negotiate drug prices with pharmaceutical companies, which often results in lower prices than in the U.S., where market forces play a more significant role. For more information, see the FAQs on Prescription Drug Importation from the Kaiser Family Foundation (KFF): https://www.kff.org/health-costs/issue-brief/faqs-on-prescription-drug-importation/

How much is the shipping?

Our shipping fee is a flat rate of $10.00 per order. Our pharmacy is dedicated to providing you with the lowest prices on high-quality products.

How do I place an order with your pharmacy?

Ordering from us is very simple. You can purchase online or call Customer Service at 1866.920.3784. Visit our How to Order page for more information or to learn about the ordering process.

Is there a limit on the number of tablets I can order at one time?

CanadaPharmacyOnline.com can only dispense a maximum of a three-month supply of Steglatro at a time, as per your doctor's prescription.

Can I buy over the counter from you?

No, Steglatro requires a valid prescription from your doctor. We do not sell this product without a valid prescription.

Do you ship to the United States?

Yes, we do. It typically takes 7-18 business days for your order to be delivered from our pharmacy.

Is there a generic for Steglatro?

No, the generic ertugliflozin is not available.

Blog Post

Four Diabetic Friendly Recipes to Enhance Your Daily Breakfast Routine
A Bowl of Oatmeal a Day May Reduce Your Risk of Type 2 Diabetes
Is the High-fat Ketogenic Diet for Health Too Good to Be True?

Latest News

New fat-burning diabetes pill protects muscle and appetite (published on December 7, 2025)
More weight-loss drugs could be offered as part of new diabetes care (published on August 7, 2025)

Similar Drugs in the category of Diabetic Medications and Products:

Jardiance Farxiga Rybelsus Januvia Tradjenta

The information on this page is sourced from independent third parties contracted by CanadaPharmacyOnline. While we cannot guarantee its medical accuracy, we strongly recommend consulting a healthcare professional for personalized advice regarding medications or medical conditions.

Reviews From Real Customers